Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma

BACKGROUND: Lung squamous cell carcinoma (LUSC) generally correlates with poor clinical prognoses due to the lack of available prognostic biomarkers. This study is designed to identify a potential biomarker significant for the prognosis and treatment of LUSC, so as to provide a scientific basis for...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cailian, Gu, Xuyu, Zhang, Xiuxiu, Zhou, Min, Chen, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569707/
https://www.ncbi.nlm.nih.gov/pubmed/34745990
http://dx.doi.org/10.3389/fonc.2021.756096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569707/
https://www.ncbi.nlm.nih.gov/pubmed/34745990
http://dx.doi.org/10.3389/fonc.2021.756096

Ejemplares similares